Surgical Complications Requiring an Early Relaparotomy in HIV-Infected Liver Transplant Recipients: Risk Factors and Impact on Survival.


Journal

Transplantation proceedings
ISSN: 1873-2623
Titre abrégé: Transplant Proc
Pays: United States
ID NLM: 0243532

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 09 01 2019
revised: 26 02 2019
accepted: 13 03 2019
pubmed: 15 10 2019
medline: 21 1 2020
entrez: 15 10 2019
Statut: ppublish

Résumé

We aimed to analyze the risk factors for early surgical complications requiring relaparotomy and the related impact on overall survival (OS) in HIV-infected patients submitted to liver transplantation. We performed a retrospective study on a nationwide multicenter cohort of 157 HIV-infected patients submitted to liver transplantation in 6 Italian transplant units between 2004 to 2014. The median preoperative model for end-stage liver disease score was 18 (interquartile range 12-26.5). An early relaparotomy was performed in 24.8% of patients, and the underlying clinical causes were biliary leak (8.2%), bleeding (8.2%), intestinal perforation (4.5%), and suspected vascular complications (3.8%). The OS at 1, 3, and 5 years was 74.3%, 68.0%, and 60.0%, respectively, and an early relaparotomy was not a prognostic factor itself, but an increasing number of relaparotomies was associated with decreased survival (hazard ratio = 1.40, 95% confidence interval [CI] 1.07-1.81, P = .01). In the multivariate analysis, preoperative refractory ascites (odds ratio 3.32, 95% CI 1.18-6.47, P = .02) and Roux-en-Y choledochojejunostomy reconstruction (odds ratio 12.712, 95% CI 2.47-65.38, P ≤ .01) were identified as significant risk factors for early relaparotomy. In HIV-infected liver transplant recipients, an increasing number of early relaparotomies due to surgical complications did negatively affect the OS. Preoperative refractory ascites reflecting a severe portal hypertension and a difficult biliary tract reconstruction requiring a Roux-en-Y choledochojejunostomy were associated with an increased risk of early relaparotomy.

Identifiants

pubmed: 31607626
pii: S0041-1345(19)30053-3
doi: 10.1016/j.transproceed.2019.03.085
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2977-2980

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Riccardo Pravisani (R)

Liver-Kidney Transplant Unit, Department of Medicine, University of Udine, Udine, Italy.

Umberto Baccarani (U)

Liver-Kidney Transplant Unit, Department of Medicine, University of Udine, Udine, Italy. Electronic address: umberto.baccarani@uniud.it.

Miriam Isola (M)

Division of Medical Statistic, Department of Medicine, University of Udine, Udine, Italy.

Federico Mocchegiani (F)

Clinica di Chirurgia Epato-bilio-pancreatica e dei Trapianti, Dipartimento di Medicina Sperimentale e Clinica, Università Politecnica delle Marche, Ancona, Italy.

Andrea Lauterio (A)

General Surgery & Abdominal Transplantation, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.

Elda Righi (E)

Division of Infectious Diseases, ASUIUD, Udine, Italy.

Paolo Magistri (P)

Hepatopancreatobiliary Surgery and Liver Transplantation Unit, University of Modena and Reggio Emilia, Modena, Italy.

Vittorio Corno (V)

Chirurgia Generale 3, Trapianti Addominali, Ospedale Papa Giovanni XXIII, Bergamo, Italy.

Gian Luigi Adani (GL)

Liver-Kidney Transplant Unit, Department of Medicine, University of Udine, Udine, Italy.

Dario Lorenzin (D)

Liver-Kidney Transplant Unit, Department of Medicine, University of Udine, Udine, Italy.

Stefano Di Sandro (S)

General Surgery & Abdominal Transplantation, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.

Duilio Pagano (D)

IRCCS ISMETT-UPMC, Palermo, Italy.

Matteo Bassetti (M)

Division of Infectious Diseases, ASUIUD, Udine, Italy.

Salvatore Gruttadauria (S)

IRCCS ISMETT-UPMC, Palermo, Italy.

Luciano De Carlis (L)

Clinica di Chirurgia Epato-bilio-pancreatica e dei Trapianti, Dipartimento di Medicina Sperimentale e Clinica, Università Politecnica delle Marche, Ancona, Italy; School of Medicine, University of Milano-Bicocca, Milano, Italy.

Marco Vivarelli (M)

Clinica di Chirurgia Epato-bilio-pancreatica e dei Trapianti, Dipartimento di Medicina Sperimentale e Clinica, Università Politecnica delle Marche, Ancona, Italy.

Fabrizio Di Benedetto (F)

Hepatopancreatobiliary Surgery and Liver Transplantation Unit, University of Modena and Reggio Emilia, Modena, Italy.

Andrea Risaliti (A)

Liver-Kidney Transplant Unit, Department of Medicine, University of Udine, Udine, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH